Paper41317985
Radiation Therapy for Gastric Cancer: An ASTRO Clinical Practice Guideline.
Anker CJ and 20 others. Pract Radiat Oncol, 2026. Cited by 2 papers, by iCite.
Cite this record
ConductScience Library. Radiation Therapy for Gastric Cancer: An ASTRO Clinical Practice Guideline. Papers, record 41317985. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41317985
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics3
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Stomach Neoplasms | Major topic |
| Humans | |
| Radiation Oncology |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| R50 CA275877 | NCI NIH HHS | United States | R50CA275877 | PubMed |
Source NIH RePORTER
References87
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 35753555 | Incidence and survival of patients with oligometastatic esophagogastric cancer: A multicenter cohort study. | Radiother Oncol | 2022 | https://conductscience.org/library/papers/35753555 | PubMed |
| 2 | 31959340 | Preoperative cisplatin, fluorouracil, and docetaxel with or without radiotherapy after poor early response to cisplatin and fluorouracil for resectable oesophageal adenocarcinoma (AGITG DOCTOR): results from a multicentre, randomised controlled phase II trial. | Ann Oncol | 2020 | https://conductscience.org/library/papers/31959340 | PubMed |
| 3 | 20215786 | Adjuvant chemotherapy with etoposide, adriamycin and cisplatin compared with surgery alone in the treatment of gastric cancer: a phase III randomized, multicenter, clinical trial. | Oncology | 2010 | https://conductscience.org/library/papers/20215786 | PubMed |
| 4 | 33858353 | Role of palliative radiotherapy in bleeding control in patients with unresectable advanced gastric cancer. | BMC Cancer | 2021 | https://conductscience.org/library/papers/33858353 | PubMed |
| 5 | 20171517 | Radiation dose-volume effects in the spinal cord. | Int J Radiat Oncol Biol Phys | 2010 | https://conductscience.org/library/papers/20171517 | PubMed |
| 6 | 37548812 | Addition of docetaxel to S-1 results in significantly superior 5-year survival outcomes in Stage III gastric cancer: a final report of the JACCRO GC-07 study. | Gastric Cancer | 2023 | https://conductscience.org/library/papers/37548812 | PubMed |
| 7 | 35938363 | Epidemiology of Gastric Cancer in Korea: Trends in Incidence and Survival Based on Korea Central Cancer Registry Data (1999-2019). | J Gastric Cancer | 2022 | https://conductscience.org/library/papers/35938363 | PubMed |
| 8 | 34446261 | The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. | Rev Esp Cardiol (Engl Ed) | 2021 | https://conductscience.org/library/papers/34446261 | PubMed |
| 9 | 40454643 | Perioperative Durvalumab in Gastric and Gastroesophageal Junction Cancer. | N Engl J Med | 2025 | https://conductscience.org/library/papers/40454643 | PubMed |
| 10 | 23608834 | Concurrent involved-field radiotherapy and XELOX versus XELOX chemotherapy alone in gastric cancer patients with postoperative locoregional recurrence. | Am J Clin Oncol | 2015 | https://conductscience.org/library/papers/23608834 | PubMed |
| 11 | 38073160 | The impact of sex on treatment and outcome in relation to histological subtype in patients with resectable gastric cancer: Results from the randomized CRITICS trial. | J Surg Oncol | 2024 | https://conductscience.org/library/papers/38073160 | PubMed |
| 12 | 22985776 | A randomized, controlled, multicenter study comparing intensity-modulated radiotherapy plus concurrent chemotherapy with chemotherapy alone in gastric cancer patients with D2 resection. | Radiother Oncol | 2012 | https://conductscience.org/library/papers/22985776 | PubMed |
| 13 | 34580795 | Treatment response after palliative radiotherapy for bleeding gastric cancer: a multicenter prospective observational study (JROSG 17-3). | Gastric Cancer | 2022 | https://conductscience.org/library/papers/34580795 | PubMed |
| 14 | 26822397 | Gastrectomy plus chemotherapy versus chemotherapy alone for advanced gastric cancer with a single non-curable factor (REGATTA): a phase 3, randomised controlled trial. | Lancet Oncol | 2016 | https://conductscience.org/library/papers/26822397 | PubMed |
| 15 | 25559811 | Phase III Trial to Compare Adjuvant Chemotherapy With Capecitabine and Cisplatin Versus Concurrent Chemoradiotherapy in Gastric Cancer: Final Report of the Adjuvant Chemoradiotherapy in Stomach Tumors Trial, Including Survival and Subset Analyses. | J Clin Oncol | 2015 | https://conductscience.org/library/papers/25559811 | PubMed |
| 16 | 38572751 | Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. | CA Cancer J Clin | 2024 | https://conductscience.org/library/papers/38572751 | PubMed |
| 17 | 36809197 | Stereotactic radiation therapy for oligometastatic esophagogastric adenocarcinoma: outcome and prognostic factors. | Br J Radiol | 2023 | https://conductscience.org/library/papers/36809197 | PubMed |
| 18 | 25687854 | Palliative Radiotherapy in the Presence of Well-Controlled Metastatic Disease after Initial Chemotherapy May Prolong Survival in Patients with Metastatic Esophageal and Gastric Cancer. | Cancer Res Treat | 2015 | https://conductscience.org/library/papers/25687854 | PubMed |
| 19 | 27384158 | Adjuvant Chemotherapy for Advanced Gastric Cancer in Elderly and Non-elderly Patients: Meta-Analysis of Randomized Controlled Trials. | Cancer Res Treat | 2017 | https://conductscience.org/library/papers/27384158 | PubMed |
| 20 | 31908720 | Asian Americans have better outcomes of non-metastatic gastric cancer compared to other United States racial groups: A secondary analysis from a randomized study. | World J Gastrointest Oncol | 2019 | https://conductscience.org/library/papers/31908720 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 42888364 | Palliative radiotherapy for gastric cancer-related bleeding: a systematic review and meta-analysis of bleeding response and dose-response relationships. | Jpn J Radiol | 2026 | https://conductscience.org/library/papers/42888364 |
Source PubMed
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41317985
GET https://conductscience.org/api/papers/v1/41317985/authors?page=2